The deal for the privately held U.K.-based biotechnology agency will assist bolster Novartis’s oncology capabilities.
Source link
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Related Posts
The Best Unlimited Phone Plan: T-Mobile, AT&T, Verizon Compared
“Limitless” is a humorous time period. Limitless cellular phone plans typically include a protracted checklist of footnotes, phrases, situations, and…
AI Washing Could Take Customers to Cleaners
As synthetic intelligence dominates company messaging, exaggerated claims — generally known as “AI washing” — could also be masking layoffs,…
JBL Bar 500MK2 Review: A Fantastic Soundbar System
The subwoofer is not any joke, at about 13 x 16 inches and 18 kilos, but it surely’s not one…